NASDAQ · AIRS

AirSculpt Technologies, Inc.

Healthcare · Medical - Care Facilities

$2.28▼ 1.09% ($0.03)today

As of 3:16 PM ET

52-week

$1.51$12.00

Market cap

$160.49M

P/E

No multiple

What the market price implies · Reverse DCF

Historical revenue grew by 3.3%/yr over the past 4 years.

Selected forecast · Base scenario

0.8%/yr · actual 10-year annualized revenue growth

Year 1 growth: 0%

Market-implied · Base operating assumptions + edited margins

Unavailable · flat 10-year annualized revenue growth

Reverse DCF solves revenue growth itself using Base operating assumptions and your edited margins. Changing forecast growth alone does not change the implied rate. This is a model-implied requirement, not an analyst forecast.

No supported revenue growth rate matches this price with these operating assumptions.

Valuation

Recommended · Revenue & margin DCF

Price used

$2.28

Estimated value / share

Unavailable

Base scenario

USD · TTM ending 2026-06-30

Every projected year produces negative free cash flow, so the model returns a negative enterprise value. A discounted-cash-flow valuation cannot be defended on those inputs, so it is not shown.

Year 1 growth 0% · Ending margin 0% · Discount rate 15.68%

Assumption scenarios, not statistical confidence intervals.

Method, dates & sources

Estimated from future revenue, operating margins, and the investment needed to support them.

Price timestamp: Sep 18, 2026, 7:16 PM UTC
Financial statement period: TTM ending 2026-06-30
Data refreshed: Sep 18, 2026, 7:16 PM UTC · provider

Why this method?

There is not a stable run of positive FCFF to anchor a direct cash-flow CAGR, so the model should start from revenue and margin assumptions instead.

Is FCFF positive and has it been for 3+ consecutive years? Only 1 consecutive positive FCFF years are available.

Price vs Fundamentals

Why The Stock Is Moving

Mixed / unclearLow confidence

1Y Price: -63.01%Revenue (TTM): -8.71%FCF (TTM): 483.84%P/S: 11th pct

What changed

The stock fell 63.01% over the last year. Revenue declined 8.71% over the trailing twelve months. Operating margin moved from -5.24% to -7.85%. Free cash flow grew 483.84% over the trailing twelve months.

What the market seems to be pricing

The stock has moved lower against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.

What would invalidate this read

Operating margin currently stands at -7.85%. A decisive move in revenue — currently down 8.71% — would be the clearest signal to resolve the ambiguity.

Performance

Return analysis

Company profile

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.

CEOYogi Jashnani

SectorHealthcare

IndustryMedical - Care Facilities

Employees347

IPO dateOct 29, 2021

http://www.airsculpt.com

Market multiples

Forward P/E—

EV/EBITDA159.55

Enterprise value$194.81M

Stock splits

No stock splits recorded for this ticker.

Profitability & growth

Revenue growth-2.53%

Gross margin (FY2025)59.37%▼1.1ppvs FY2024

Operating margin (FY2025)-3.18%▼2.2ppvs FY2024

ROE-11.98%▲2.0ppvs FY2025

Analyst consensus

RatingHold

Target price$4.50▲97.80%

Buy

Hold

Sell

Analyst ratings tend to be lagging indicators. Use as one signal among many.

Earnings

Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.

Next report

Nov 9, 2026

Q4 FY26 · EPS est -$0.03 · Revenue est $34.51M

View